Home » Newsletters » BioWorld

BioWorld

Feb. 25, 1992

View Archived Issues

TSI SHARES ELIGIBLE FOR CONVERSION

CAMBRIDGE BIO ENTERS PRIVATE LABEL PACT

ONCOTECH TO DEVELOP IMUVERT

CIBA TO TEST APHTON IMMUNE STIMULANTS

MEDICIS WARRANT REDEMPTION RAISES $14M

MYCOGEN ADOPTS POISON PILL

SOMATOGEN BLOOD SUBSTITUTE ENTERS TRIALS

ICOS BACK TO THE FUNDING WELL

GRANT FOR DNA IDENTIFICATION SYSTEM

MGI FILES FOR SALAGEN APPROVAL

RISK POLICY PAVES WAY FOR BIOTECH RULES

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...